Reverse Transcription-Loop-mediated Isothermal Amplification (RT-LAMP) Assay for Zika Virus and Housekeeping Genes in Urine, Serum, and Mosquito Samples
September 14th, 2018
13.3K views
This protocol provides an efficient and low-cost method to detect Zika virus or control targets in human urine and serum samples or in mosquitoes by reverse transcription loop-mediated isothermal amplification (RT-LAMP). This method does not require RNA isolation and can be done within 30 min.
Overview
This protocol provides a rapid and cost-effective method for detecting Zika virus in human urine, serum samples, or mosquitoes using reverse transcription loop-mediated isothermal amplification (RT-LAMP). The technique is advantageous as it does not require RNA isolation and can be completed in approximately 30 minutes.
Key Study Components
Area of Science
- Virology
- Infectious Diseases
- Diagnostic Techniques
Background
- Zika virus poses significant health risks, particularly during pregnancy.
- Infection can lead to severe congenital and neurological defects.
- Current diagnostic methods may be time-consuming and costly.
- RT-LAMP offers a rapid alternative for Zika detection.
Purpose of Study
- To provide a quick diagnostic tool for Zika virus detection.
- To facilitate monitoring of mosquito populations at risk for Zika.
- To support reproductive health by aiding in Zika infection diagnosis.
Methods Used
- Reverse transcription loop-mediated isothermal amplification (RT-LAMP).
- Sample analysis from human urine, serum, and mosquitoes.
- Use of virus-specific primers for detection.
- Rapid processing time of approximately 30 minutes.
Main Results
- Efficient detection of Zika virus in various sample types.
- Method demonstrated to be user-friendly and cost-effective.
- No requirement for RNA isolation simplifies the process.
- Potential applicability to other viruses like dengue and chikungunya.
Conclusions
- RT-LAMP is a promising tool for rapid Zika virus diagnosis.
- The method can enhance surveillance efforts for Zika and related viruses.
- Further research may expand its use to other infectious diseases.
Frequently Asked Questions
What is RT-LAMP?
RT-LAMP is a rapid diagnostic technique that amplifies RNA without the need for RNA isolation.
How long does the RT-LAMP process take?
The entire RT-LAMP process can be completed in approximately 30 minutes.
Can this method be used for other viruses?
Yes, RT-LAMP can be adapted for detection of other viruses such as dengue and chikungunya.
What are the implications of Zika virus infection?
Zika virus infection during pregnancy can lead to miscarriage, stillbirth, and severe congenital defects.
Is this method cost-effective?
Yes, RT-LAMP is designed to be a low-cost alternative for virus detection.
Who can benefit from this diagnostic method?
Pregnant women, couples trying to conceive, and public health officials monitoring mosquito populations can benefit from this method.
Executive Industry Relevance
Rapid, equipment-free detection of Zika virus in clinical and vector samples supports early intervention in reproductive health and outbreak surveillance. RT-LAMP enables decentralized testing without RNA extraction, reducing time-to-result and infrastructure burden. This approach enhances predictive confidence in target validation for antiviral development and vector control strategies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional interrogation of viral presence in human biofluids and mosquito tissues to confirm target engagement.
- Operational Value: Eliminates RNA isolation step, simplifying workflow for high-throughput screening of clinical specimens.
- Predictive Value: Provides qualitative readout to triage samples for downstream quantification or sequencing.
Screening & Assay Development
- Scientific Value: Uses virus-specific primers to detect ZIKV with demonstrated specificity against asymptomatic controls and related arboviruses.
- Operational Value: Compatible with visual detection via color change or UV fluorescence, enabling low-resource assay formats.
- Scalability: Supports pooled testing of mosquito homogenates for surveillance applications.
Translational & Preclinical Research
- Scientific Value: Detects ZIKV in urine and serum of infected patients, establishing clinical relevance for vertical transmission risk assessment.
- Operational Value: Utilizes housekeeping genes (18S rRNA in humans, actin in mosquitoes) as internal controls to validate sample integrity.
- Predictive Value: Enables longitudinal monitoring of viral load dynamics in model systems without invasive sampling.
Pipeline & Workflow Integration
RT-LAMP fits within the discovery continuum from initial hypothesis testing in vector biology to preclinical evaluation of antiviral candidates, particularly where rapid sample triage is needed.
- Discovery Biology: Supports target validation by confirming viral presence in urine, serum, and mosquito samples to interrogate transmission pathways.
- Screening: Enables assay-ready sample preparation with visual or fluorescent readouts for high-throughput compatibility.
- Analytics: Generates binary (positive/negative) and semi-quantitative data via gel electrophoresis for comparative condition analysis.
- Translational Research: Bridges detection in human samples to mechanistic studies of congenital risk in preclinical models.
- Enterprise Reuse: Primer design framework allows rapid adaptation to emerging arboviruses (e.g., dengue, chikungunya) using same core protocol.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in viral detection by providing specific, equipment-free readout.
- Operational Value: Enables decentralized testing with minimal instrumentation (heat block or water bath).
- Strategic Value: Accelerates go/no-go decisions in antiviral screening by rapidly confirming target modulation.
- Portfolio Impact: Supports risk-adjusted prioritization of compounds based on target engagement in clinically relevant matrices.
Implementation Considerations
- Requires molecular biology expertise in primer design and nucleic acid handling.
- Needs thermal incubation device (61°C for 30 min, 80°C for 10 min) and UV transilluminator for validation.
- Demands segregated workflow to prevent amplicon contamination and false positives.
- Requires optimization across sample types (urine, serum, mosquito lysate) to account for inhibitors.
- Limited to qualitative or semi-quantitative output unless paired with qPCR for viral load quantification.
Biopharma FAQs
Why does visual color change matter for ZIKV detection in urine?
The fluorescent nucleic acid dye produces a yellow-green color in positive RT-LAMP reactions and orange in negatives, enabling visual readout without instrumentation. This allows rapid assessment of ZIKV presence in clinical urine samples from infected patients, supporting point-of-care triage.
How does isolating the independent variable (viral RNA) improve target validation in mosquito surveillance?
By using whole mosquito homogenates without RNA isolation, the assay tests for viral RNA in its native matrix, preserving potential inhibitors or enhancers present in tissue. This approach validates whether ZIKV can be detected directly from crushed Aedes aegypti carcasses, reflecting real-world surveillance conditions.
What quantitative dependent variable measurements enable hit confirmation in antiviral screening?
Agarose gel electrophoresis generates banding patterns for positive RT-LAMP reactions, allowing semi-quantitative comparison of amplification intensity across conditions. This enables researchers to compare ZIKV signal strength in treated versus untreated samples to assess compound effects on viral replication.
Why do replication requirements matter for cross-functional collaboration in outbreak response?
The protocol includes positive and negative controls, as well as specificity controls for related viruses like dengue, to ensure reproducibility across laboratories. Consistent detection of ZIKV in patient urine and serum, but not in asymptomatic controls, allows reliable data sharing between public health, clinical, and research teams.
What statistical analysis capabilities are required before implementing RT-LAMP for large-scale screening?
No statistical analysis is built into the RT-LAMP readout, which relies on visual or fluorescent detection of amplification. For scalable implementation, users must establish false positive rates through replicate testing and apply orthogonal confirmation (e.g., qPCR) when quantitative thresholds are needed for decision-making.
